Detalles de la búsqueda
1.
Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis.
Haematologica
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38752279
2.
The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation.
Br J Haematol
; 203(5): 840-851, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37614192
3.
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.
Haematologica
; 108(12): 3321-3332, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37408464
4.
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia.
Am J Hematol
; 98(12): 1869-1876, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37688521
5.
Human Herpesvirus 6 DNAemia Is Associated With Worse Survival After Ex Vivo T-Cell-Depleted Hematopoietic Cell Transplant.
J Infect Dis
; 225(3): 453-464, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34390240
6.
Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort Study.
Clin Infect Dis
; 75(5): 795-804, 2022 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34979021
7.
Cytomegalovirus Viral Load Kinetics Predict Cytomegalovirus End-Organ Disease and Mortality After Hematopoietic Cell Transplant.
J Infect Dis
; 224(4): 620-631, 2021 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33864371
8.
Adenovirus Viral Kinetics and Mortality in Ex Vivo T Cell-Depleted Hematopoietic Cell Transplant Recipients With Adenovirus Infection From a Single Center.
J Infect Dis
; 222(7): 1180-1187, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32374872
9.
A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(6): 1195-1202, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32088367
10.
Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 26(2): 323-332, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31618690
11.
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(8): 1526-1535, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30831208
12.
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(6): 1136-1141, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30625387
13.
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis.
Biol Blood Marrow Transplant
; 25(6): 1142-1151, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30625392
14.
Phase 1/2 Trial of Carfilzomib Plus High-Dose Melphalan Preparative Regimen for Salvage Autologous Hematopoietic Cell Transplantation Followed by Maintenance Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma.
Biol Blood Marrow Transplant
; 24(7): 1379-1385, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29410301
15.
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 24(12): 2517-2522, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30055353
16.
Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(1): 142-149, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28951193
17.
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 24(1): 133-141, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28870777
18.
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(5): 1079-1087, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29325829
19.
Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Older Patients with Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 23(7): 1078-1086, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28336325
20.
T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies.
Biol Blood Marrow Transplant
; 23(10): 1685-1694, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28734876